Axogen, Inc. (AXGN)

Name: Axogen, Inc. (AXGN) annual fundamentals
Creator: TickerFacts
License: https://creativecommons.org/publicdomain/zero/1.0/

Build a valuation ↗↓ Download CSV

CIK 0000805928 · Nasdaq · Electromedical & Electrotherapeutic Apparatus

Sector Manufacturing
Incorporated MN
Fiscal year ends Dec 31

For the year ended 2025-12-31, Axogen, Inc. reported revenue of $225.21M. Revenue grew 20.2% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $251.17M.

Key ratios (year ended 2025-12-31)

74.3%

Gross margin

-3.5%

Operating margin

-7.0%

Net margin

-12.2%

Return on year-end equity

20.2%

Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2026-10-01

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period ended	TTM to 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31
Revenue	$251.17M	$225.21M	$187.34M	$159.01M	$138.58M	$127.36M	$112.30M	$106.71M	$83.94M	$60.43M	$41.11M
Cost of Revenue	$63.91M	$57.85M	$45.36M	$37.14M	$29.77M	$22.93M	$21.58M	$17.35M	$12.92M	$9.31M	$6.47M
Gross Profit	$187.26M	$167.35M	$141.98M	$121.87M	$108.81M	$104.43M	$90.72M	$89.36M	$71.01M	$51.12M	$34.64M
R&D Expense	$36.05M	$32.88M	$27.77M	$27.34M	$25.63M	$24.18M	$17.85M	$17.51M	$11.77M	$6.70M	$4.21M
Operating Income	-$12.85M	-$7.85M	-$3.29M	-$21.46M	-$29.71M	-$25.42M	-$23.18M	-$31.41M	-$20.50M	-$7.95M	-$8.13M
Depreciation & Amortization	$6.49M	$6.66M	$6.47M	$4.22M	$2.83M	$2.74M	$1.53M	n/a	n/a	n/a	n/a
EBITDA	-$6.36M	-$1.19M	$3.18M	-$17.24M	-$26.88M	-$22.67M	-$21.65M	n/a	n/a	n/a	n/a
Net Income	-$33.55M	-$15.70M	-$9.96M	-$21.72M	-$28.95M	-$26.98M	-$23.79M	-$29.14M	-$22.40M	-$10.45M	-$14.41M
EPS (Diluted)	n/a	-$0.34	-$0.23	-$0.51	-$0.69	-$0.65	-$0.60	-$0.74	n/a	n/a	n/a
Total Assets	$304.86M	$221.69M	$203.73M	$196.83M	$195.39M	$208.02M	$201.38M	$154.64M	$160.17M	$58.88M	$46.36M
Total Liabilities	$48.61M	$92.84M	$99.82M	$101.16M	$94.39M	$95.47M	$78.23M	$22.49M	$13.19M	$33.69M	$31.44M
Long-Term Debt	n/a	$48.39M	$47.50M	$46.60M	$45.71M	$44.82M	$32.03M	$0	n/a	n/a	n/a
Shareholders' Equity	$256.26M	$128.85M	$103.91M	$95.67M	$101.00M	$112.55M	$123.15M	$132.15M	$146.98M	$25.18M	$14.92M
Cash & Equivalents	$94.57M	$35.55M	$27.55M	$31.02M	$15.28M	$32.76M	$48.77M	$35.72M	$24.29M	$36.51M	$30.01M
Operating Cash Flow	$15.05M	$812.0K	$4.54M	-$5.72M	-$16.07M	-$13.40M	-$9.63M	-$19.87M	-$17.86M	-$9.24M	-$11.24M
Capital Expenditures	$6.45M	$3.75M	$3.10M	$13.87M	$20.08M	$27.81M	$21.91M	$4.66M	$6.28M	$1.10M	$931.0K
Free Cash Flow	$8.60M	-$2.93M	$1.43M	-$19.59M	-$36.14M	-$41.22M	-$31.53M	-$24.54M	-$24.14M	-$10.34M	-$12.17M
Shares Outstanding	53.66M	47.20M	44.15M	43.12M	42.45M	41.74M	40.62M	39.59M	38.90M	34.35M	33.01M
Weighted Average Diluted Shares	n/a	46.05M	44.26M	42.88M	42.08M	41.21M	39.97M	39.23M	n/a	n/a	n/a
EPS (Basic)	n/a	-$0.34	-$0.23	-$0.51	-$0.69	-$0.65	-$0.60	-$0.74	n/a	n/a	n/a

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView